05/18
Headlines

BioTech

Bluebirdbio BLUE NASDAQ BLUE

Healthcare Gainers: Gentiva Health Services (NASDAQ:GTIV), bluebird bio Inc (NASDAQ:BLUE), Celldex Therapeutics (NASDAQ:CLDX), Intercept Pharmaceuticals (NASDAQ:ICPT), Northwest Biotherapeutics (NASDAQ:NWBO)

Mark DeFrance04 mins

Gentiva Health Services Inc. (NASDAQ:GTIV)’s rejection of the takeover proposal from Kindred Healthcare Inc. ( KND ) is hitting headlines and drawing investor attention to the healthcare space. Gentiva Health Services, Inc. (NASDAQ:GTIV) stock performance was -1.52% in last session and finished the day at $13.62. Traded volume was 1.47million shares in the last session…

Read More
BBRY NASDAQ BBRY Blackberry

Hot Stocks: BlackBerry Ltd (NASDAQ:BBRY), Comtech Telecomm. Corp. (NASDAQ:CMTL), Cempra Inc (NASDAQ:CEMP), Aaron’s, Inc. (NYSE:AAN)

John Bellich02 mins

BlackBerry (NASDAQ:BBRY) was upgraded by investment analysts at Oppenheimer from an “underperform” rating to a “market perform” rating in a note issued to investors on Tuesday, Analyst RN reports. BlackBerry Ltd (NASDAQ:BBRY) stock performance was -3.28% in last session and finished the day at $ 7.67. Traded volume was 150.00 million shares in the last…

Read More
Gilead Sciences GILD NASDAQ:GILD

Active Stocks: Endocyte (NASDAQ:ECYT), Gilead Sciences, Inc. (NASDAQ:GILD), Arena Pharmaceuticals (NASDAQ:ARNA), Immunomedics (NASDAQ:IMMU)

Adam Keintzel02 mins

Endocyte (NASDAQ:ECYT)’s shares saw strong trading volume on Friday after the company announced better than expected quarterly earnings, American Banking and Market News reports. 13,778,961 shares changed hands during trading, an increase of 624% from the previous session’s volume of 1,903,723 shares. Endocyte, Inc. (NASDAQ:ECYT) stock performance was 61.91% in last session and finished the…

Read More
Avanir Pharmaceuticals

Small Cap Losers: Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Monster Worldwide (NYSE:MWW), Key Energy Services (NYSE:KEG), McEwen Mining (NYSE:MUX)

Kevin Long02 mins

Shares of Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) soared 45.6% after the company announced that the U.S. District Court for the District of Delaware has ruled the patent infringement lawsuit against Par Pharmaceuticals, Inc. and Impax Laboratories, Inc. ( IPXL ) in its favor. Avanir Pharmaceuticals Inc (NASDAQ:AVNR) stock performance was -6.63% in last session and finished…

Read More

Biotech Early Movers: OncoGenex Pharmaceuticals Inc(NASDAQ:OGXI), Agenus Inc(NASDAQ:AGEN), Athersys, Inc.(NASDAQ:ATHX)

Colin Pettis03 mins

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) shares plunged more than 48% pre-market after the company said results from its Phase 3 SYNERGY trial to add custirsen to standard first-line treatment of docetaxel/prednisone in men with metastatic prostate cancer failed to meet primary endpoints. The stock which was halted from trading ahead of the news, recently changed hands…

Read More